Clinical Research Directory
Browse clinical research sites, groups, and studies.
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
Sponsor: OncoHost Ltd.
Summary
The goal of this exploratory study is understand the mechanisms of response to immunotherapy in Non-Small Cell Lung Cancer patients. The investigators are going to search for correlation between specific biological features and response to immunotherapy, and to use those associations for developing an algorithm enabling to identify patients that could benefit from the immune check inhibitor based anti cancer treatment. Patients will provide biological samples before and during their treatment, and clinical data will be collected.
Official title: PROPHETIC Extended - Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Extended Study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
350
Start Date
2022-11-07
Completion Date
2028-06-30
Last Updated
2023-02-21
Healthy Volunteers
Yes
Conditions
Interventions
blood, stool and tissue samples collection
blood, stool and tissue samples collection before and during the treatment, as applicable
Locations (1)
Baylor Scott and White Research Institute
Dallas, Texas, United States